Breast Cancer Is Rising Among Women: The Menopause Connection, Early Screening and the Healthcare Gap Millions Still Face

Breast cancer is affecting more women, including women under 50. At the same time, Black women continue to face a disproportionate risk of dying from the disease, while cost, insurance gaps and unequal access to screening can delay diagnosis. As researchers investigate the role of hormones, menopause, reproductive history and metabolic health, a larger question is emerging: Are women getting the information, screenings and care they need early enough?

Breast cancer is one of the most pressing health issues facing women in the United States. It is a disease that touches families across generations, yet the experience of finding it, receiving a diagnosis and getting treatment can look very different depending on a woman’s age, race, income, insurance coverage and where she lives.

The conversation is also changing. Breast cancer is no longer being discussed only as a disease affecting older women. Diagnoses have been increasing among younger women, and researchers are examining a wider range of possible contributing factors. Meanwhile, women are navigating menopause, changing hormone levels, weight and metabolic changes, and other health concerns that can make it difficult to know which symptoms deserve attention and when screening should begin.

There is an important distinction: menopause does not cause breast cancer, and the rise in diagnoses cannot be explained by hormones alone. But hormonal exposure, reproductive history and certain menopause treatments are relevant to breast cancer risk. Understanding those relationships is part of giving women better information and helping them make informed decisions.

Just as important is making sure that early detection is not a privilege available only to women who can afford it.

The numbers behind the increase

The American Cancer Society estimates that approximately 321,910 women will be diagnosed with invasive breast cancer in the United States in 2026. Another 60,730 cases of ductal carcinoma in situ (DCIS), a non-invasive form of breast cancer, are expected. Approximately 42,140 women are expected to die from the disease this year. 

American Cancer Society

The lifetime risk for an American woman developing breast cancer is approximately one in eight. That does not mean every woman has the same risk. Age, family history, inherited genetic changes, reproductive history, previous breast conditions and other factors all influence an individual’s likelihood of developing the disease.

One of the most significant developments is the increase among younger women. Breast cancer incidence has been increasing by approximately 1% annually in recent years, with a faster increase of about 1.4% annually among women younger than 50. 

American Cancer Society

CDC data also show that breast cancer diagnoses among women younger than 45 increased between 2001 and 2022. The rate of increase became more pronounced after 2012. In 2022 alone, 27,136 new cases were reported among women younger than 45. 

CDC

This matters because women in their 30s and early 40s may not consider themselves at an age when cancer screening is necessary. Some may not have a regular primary care physician. Others may attribute breast changes, fatigue or other symptoms to pregnancy, stress, hormonal changes or the beginning of perimenopause.

The message is not that every symptom signals cancer. It is that women should not be discouraged from seeking an evaluation because they are considered too young.

There is also encouraging progress. Breast cancer death rates have declined substantially since 1989, with the American Cancer Society reporting an overall reduction of approximately 44% through 2023. Better screening, earlier diagnosis and advances in treatment have all contributed. 

American Cancer Society

The challenge is making sure those advances reach every woman.

Menopause, estrogen and the question of cancer risk

For many women, the years leading up to menopause can bring significant changes. Perimenopause may begin years before the final menstrual period, with symptoms including irregular cycles, hot flashes, night sweats, sleep problems, mood changes and shifts in weight and body composition.

Estrogen levels fluctuate during this transition and eventually decline after menopause. These changes are important to understand, but they should not be confused with a direct cause of breast cancer.

The relationship between hormones and breast cancer is better understood through lifetime hormone exposure and the biology of individual tumors.

Some breast cancers are hormone-receptor positive, meaning their growth is influenced by estrogen and/or progesterone. These cancers may respond to treatments that block hormonal activity or reduce estrogen production.

Several reproductive factors are associated with breast cancer risk, including:

• Beginning menstruation at an early age.
• Reaching menopause at a later age.
• Having a first full-term pregnancy at an older age.
• Never having a full-term pregnancy.
• Having certain reproductive or hormonal histories.

These factors can affect the length of time a woman’s body is exposed to naturally produced hormones. They do not determine whether a woman will develop cancer, but they help researchers and clinicians understand risk. 

What about hormone replacement therapy?

This is one of the most important conversations women should have with their healthcare providers during menopause.

Menopausal hormone therapy can help relieve symptoms such as hot flashes, night sweats and vaginal discomfort. But the risks depend on the type of therapy, the woman’s age, whether she has a uterus, how long she uses it and her personal medical history.

Combined estrogen-progestin therapy has been associated with an increased risk of breast cancer. Estrogen-only therapy has a different risk profile, and its use is generally limited to women who have had a hysterectomy because estrogen alone can increase endometrial cancer risk in women with an intact uterus.

This is not an argument for women to avoid treatment. It is an argument for better counseling.

Women should understand the potential benefits and risks of hormone therapy, discuss nonhormonal alternatives when appropriate, and make decisions based on their individual circumstances. A woman with a personal history of breast cancer, for example, needs a different conversation from a woman without that history.

There is another issue worth discussing: weight gain and changes in body composition around menopause. Excess body fat after menopause is associated with an increased risk of breast cancer. Fat tissue can contribute to estrogen production after the ovaries have stopped producing most of their estrogen. Excess weight is also associated with several other cancers.

That makes metabolic health, physical activity, nutrition, sleep and alcohol consumption relevant subjects in a broader discussion about women’s long-term cancer risk. None is a guarantee against cancer, but they are areas where women can discuss meaningful risk-reduction steps with their healthcare teams.

Early screening: Why waiting until something feels wrong can be dangerous

One of the biggest opportunities in breast cancer prevention and detection is getting women to understand when screening should begin and what to do if something changes.

A mammogram is designed to find breast cancer before a woman notices a lump or experiences symptoms. It can identify abnormalities that are too small to feel during a physical examination.

The U.S. Preventive Services Task Force recommends that women at average risk receive a screening mammogram every two years from age 40 through age 74. Women with a higher-than-average risk may need a different screening schedule or additional testing. 

United States Preventive Services Taskforce+1

That recommendation is important because many women still believe mammograms are something they should begin thinking about at age 50.

But screening is not a one-size-fits-all decision.

What women should consider at different ages

Women in their 20s and 30s

Routine mammography is not generally recommended for average-risk women in this age group. However, this is a good time to understand family history and discuss personal risk with a healthcare professional.

Women with a strong family history of breast or ovarian cancer, known inherited genetic mutations or previous high-risk breast conditions may need earlier assessment. A clinician may recommend genetic counseling, risk assessment, MRI or a different screening schedule.

A woman should also seek medical evaluation for a new lump, nipple discharge, skin changes or other unexplained breast symptoms, regardless of age.

Women in their 40s

This is an important decade for breast cancer screening. Average-risk women should discuss starting mammography at age 40, consistent with the USPSTF recommendation.

Women should also ask whether their family history, breast density or other risk factors suggest that additional screening is appropriate.

Women in their 50s and 60s

Regular screening remains important. Women should discuss the appropriate interval, whether their risk has changed and whether additional imaging is warranted.

Women over 74

Screening decisions should take into account overall health, life expectancy, personal preferences and medical history. The USPSTF considers the evidence insufficient to make a general recommendation for women aged 75 and older, so individualized discussion becomes especially important. 

Dense breasts: A conversation more women need to have

Breast density is another subject that deserves greater attention.

Some women have dense breast tissue, which can make mammograms more difficult to interpret because both dense tissue and cancer can appear white on the image. Dense breasts are also associated with an increased risk of breast cancer.

Women should ask whether their mammogram report identifies dense breast tissue and whether their overall risk warrants additional imaging.

Depending on individual circumstances, a healthcare professional may discuss breast ultrasound or MRI. MRI is commonly used alongside mammography for women at high risk, including some women with inherited genetic mutations or a sufficiently high calculated lifetime risk.

Additional imaging is not automatically necessary for every woman with dense breasts. It can also produce false alarms, additional testing and biopsies. The decision should be based on personal risk and a discussion of benefits and limitations. 

Genetic testing and knowing your family history

Women sometimes assume they are not at risk because nobody in their immediate family has had breast cancer. That assumption can be misleading.

Inherited changes in genes such as BRCA1 and BRCA2 can significantly increase the risk of breast and ovarian cancers. Other inherited genetic changes can also influence cancer risk.

A family history of breast, ovarian, pancreatic or certain prostate cancers may be relevant when assessing whether genetic counseling is appropriate.

Women should consider sharing information about cancer diagnoses on both sides of their family, including the age at which relatives were diagnosed.

Genetic testing is not necessary for everyone. A healthcare professional or genetic counselor can help determine whether testing is appropriate and explain what the results mean for screening and prevention.

Symptoms that should not be ignored

Breast cancer does not always begin with a noticeable lump. Women should seek medical attention for:

• A new lump or thickening in the breast or underarm.
• A change in breast size, shape or appearance.
• Skin dimpling, puckering or redness.
• New nipple inversion or unusual nipple discharge.
• Persistent breast or nipple changes that are not normal for them.

A symptom does not automatically mean cancer. Many breast changes are caused by benign conditions. But an unexplained change should be evaluated rather than simply attributed to menopause or aging.

It is also important to understand that a normal mammogram does not mean a woman should ignore a new symptom. Screening and diagnostic testing are different. A woman with symptoms may need a diagnostic mammogram, ultrasound or other evaluation even if her last screening mammogram was normal. 

The racial divide: Why Black women face a different breast cancer reality

Perhaps no part of the breast cancer conversation deserves more attention than the racial disparities in diagnosis and survival.

Black women in the United States are less likely than White women to develop breast cancer overall, yet they are significantly more likely to die from it.

The American Cancer Society reports that Black women have the highest breast cancer death rate of any racial or ethnic group. They are approximately 40% more likely to die from breast cancer than White women, despite White women having a slightly higher overall incidence rate. 

This is not simply a question of whether women are getting mammograms.

In fact, screening rates do not tell the entire story. Susan G. Komen reports that in 2023, approximately 86% of Black women aged 50 to 74 had received a screening mammogram within the previous two years, compared with 79% of White women.

Yet Black women continue to experience higher mortality. 

That raises a critical question: If women are getting screened, why are the outcomes still so different?

More aggressive breast cancer subtypes

One factor is the higher proportion of triple-negative breast cancer diagnosed among Black women.

Triple-negative breast cancer does not have estrogen receptors, progesterone receptors or excess HER2 protein. Because it lacks these three common treatment targets, some of the hormonal and targeted therapies used for other breast cancer types are not effective against it.

It can be more aggressive and may be more difficult to treat.

Black women are also more likely to be diagnosed at younger ages and with more advanced disease. These differences are part of the reason researchers are examining whether screening strategies, risk assessment and follow-up care should better account for the populations most affected. 

The problem does not end with the mammogram

An abnormal mammogram is only the beginning of the diagnostic process.

A woman may need additional imaging, a biopsy, a specialist appointment and, if cancer is found, further testing to determine the type and stage of the disease.

Each step requires time, access and resources.

Some women face delays in obtaining follow-up appointments or biopsies. Others may struggle to find a specialist, travel to a treatment center, take time away from work or manage the cost of additional procedures.

Research discussed by Susan G. Komen identifies delays in follow-up after abnormal mammograms as one factor that may contribute to disparities in outcomes for Black women. 

There are also broader issues involving the quality of care, communication between patients and providers, access to clinical trials and whether patients receive timely, appropriate treatment.

The healthcare system cannot measure success simply by counting how many women receive screening mammograms. It must also measure how quickly women receive answers when something abnormal is found.

Other minority communities face barriers, too

The experience of Black women is particularly important because of the documented mortality gap, but other communities face their own challenges.

Hispanic and Latina women may encounter language barriers, lack of insurance, limited access to a regular healthcare provider and difficulty navigating complex medical systems.

American Indian and Alaska Native women can face geographic barriers, shortages of specialists and limited access to screening and diagnostic services in rural and tribal communities.

Some Asian American and Pacific Islander women may experience language and cultural barriers, as well as differences in access to preventive care.

These communities are not medically or culturally identical, and their cancer risks vary. The common issue is that screening and treatment must be accessible, understandable and appropriate to the people receiving care.

A screening recommendation has limited value if a woman cannot afford the appointment, cannot get time off work, cannot find transportation or cannot understand the instructions she receives.

The cost of healthcare: When a mammogram is only the beginning of the bill

• Breast Cancer Awareness Is More Than a Month—It’s a Daily Commitment to Women’s Health

For many women, the cost of healthcare is not an abstract policy debate. It is a practical decision about whether to schedule an appointment, pay a bill, take time off work or delay another household expense.

A screening mammogram may be covered by insurance, but that does not mean every part of the breast cancer detection process is free.

Under the Affordable Care Act, most non-grandfathered private health insurance plans must cover recommended preventive screening mammograms for eligible women without cost-sharing. Medicare also covers screening mammography. However, coverage rules differ for diagnostic mammograms, ultrasounds, MRIs, biopsies and other follow-up procedures. Women should confirm their coverage and potential out-of-pocket costs with their insurer. 

This distinction matters.

A woman may receive a routine screening mammogram without a copayment, only to discover that an abnormal result requires a diagnostic mammogram or ultrasound. She may then need a biopsy.

Those additional procedures can bring separate bills, deductibles, coinsurance and other expenses.

For someone with a high-deductible insurance plan, even a covered service can create a substantial financial burden.

For someone without insurance, the situation can be even more difficult.

The numbers reveal a serious access problem

A CDC analysis found that approximately one in four women aged 50 to 74 had not received a mammogram in the previous two years in 2022.

Among women reporting three or more health-related social needs, approximately three in ten were not up to date with mammography.

Most strikingly, women who reported cost as a barrier to healthcare had about twice the odds of not receiving a mammogram compared with women who did not report that barrier. 

CDC

The CDC also identified several other obstacles:

• Lack of reliable transportation.
• Job loss or reduced working hours.
• Food and housing insecurity.
• Social isolation.
• Lack of a regular healthcare provider.
• Difficulty arranging childcare or eldercare.

These issues can turn a routine screening appointment into a complicated financial and logistical challenge.

Imagine a single mother who works hourly and has no paid leave. She may need to arrange childcare, lose a day’s wages and travel a considerable distance for a mammogram. If the results are abnormal, she may need to repeat that process several times.

For a woman living paycheck to paycheck, the decision can become more difficult than it should ever be.

Healthcare access involves much more than an insurance card. It includes having a provider, finding an appointment, understanding coverage, getting transportation and completing follow-up testing.

The financial impact of a cancer diagnosis

Once breast cancer is diagnosed, the financial challenges can become much greater.

Depending on the diagnosis, treatment may involve surgery, radiation, chemotherapy, hormone therapy, targeted therapies, immunotherapy or combinations of these approaches.

There may also be expenses associated with:

• Specialist consultations.
• Genetic testing.
• Fertility preservation.
• Travel and lodging near treatment centers.
• Prescription medications.
• Physical rehabilitation.
• Mental health counseling.
• Lost income and reduced working hours.
• Childcare and caregiving support.

Some women continue working through treatment because they cannot afford to stop. Others reduce their hours or leave their jobs entirely.

Even women with insurance may experience financial toxicity, a term used to describe the financial strain associated with cancer care.

This is an important part of the story because the ability to survive cancer should not depend on whether a woman can afford to keep up with her mortgage, rent, transportation and household expenses while receiving treatment.

Where women can find free or lower-cost screening

There are programs designed to help women who are uninsured, underinsured or have limited incomes.

One of the most important is the CDC’s National Breast and Cervical Cancer Early Detection Program (NBCCEDP).

The program provides free or low-cost breast and cervical cancer screening and diagnostic services to eligible women. Depending on the state program, eligibility generally includes women with limited incomes who lack adequate health insurance.

Some women may qualify for breast screening between ages 40 and 64, with exceptions for certain individuals outside that range. Income eligibility is generally at or below 250% of the federal poverty level, although program details should be checked locally. 

CDC+1

Resources women should know about

• CDC National Breast and Cervical Cancer Early Detection Program: Find a free or low-cost screening program.
• National Cancer Institute: Call 1-800-4-CANCER or visit Cancer.gov for cancer information and assistance locating screening services.
• Susan G. Komen: Breast cancer support and financial assistance resources.
• American Cancer Society: Screening, treatment and patient support information.

The CDC program is especially important because it can help with more than the initial mammogram. It also supports diagnostic services and patient navigation to help women move through the healthcare system when an abnormality is found. 

Breast cancer is part of a wider trend in cancer among younger adults

The breast cancer discussion is also taking place against a larger backdrop: researchers are investigating increases in several cancers among younger adults.

A major study published in The Lancet Public Health in 2025 examined cancer incidence trends in younger generations. Researchers found that 14 cancer types increased in at least one younger age group, including breast, colorectal, kidney, uterine and pancreatic cancers. 

This does not mean all cancers are increasing, nor does it mean that every increase has the same explanation.

But the findings have raised important questions about changes in lifestyle, obesity, environmental exposures, reproductive patterns, infections and other factors that may influence cancer risk.

Here are some of the cancers drawing particular attention.

Colorectal cancer

Colorectal cancer has become a major concern because diagnoses have increased among younger adults.

It was once commonly thought of as a cancer primarily affecting older people. Screening recommendations have changed as a result.

The USPSTF recommends colorectal cancer screening for average-risk adults beginning at age 45 and continuing through age 75. Screening options include stool-based tests and visual examinations such as colonoscopy.

Women should not assume that changes in bowel habits, rectal bleeding or persistent abdominal discomfort are simply related to diet, stress or menopause. These symptoms deserve medical evaluation.

Uterine and endometrial cancer

Uterine cancer, particularly endometrial cancer, is another important concern.

Risk factors include obesity, older age, certain hormonal exposures, a history of conditions associated with unopposed estrogen and some inherited genetic conditions.

Because endometrial cancer is often diagnosed after menopause, unexplained vaginal bleeding after menopause should never be dismissed as normal aging.

This is an area where the menopause conversation is especially important. Women need to understand the difference between expected menopausal symptoms and warning signs that require investigation.

Kidney cancer

Kidney cancer has also been included among the cancers showing increases in younger age groups.

Risk factors can include smoking, obesity, high blood pressure and certain inherited conditions.

There is no standard population-wide screening test recommended for average-risk people without symptoms. That makes awareness of personal risk and appropriate medical evaluation important.

Pancreatic cancer

Pancreatic cancer is another disease that researchers are watching closely.

It is often difficult to detect early because symptoms can be vague or absent in the initial stages. Risk factors include smoking, obesity, chronic pancreatitis, certain inherited genetic changes and family history.

There is currently no recommended routine screening test for pancreatic cancer among average-risk people. People with certain inherited risks or strong family histories may be candidates for specialized surveillance programs.

What about ovarian cancer?

Ovarian cancer deserves a place in the women’s health conversation, particularly when discussing menopause, family history and inherited genetic risk.

Symptoms can be subtle and may include persistent bloating, pelvic or abdominal pain, difficulty eating, feeling full quickly and changes in urinary habits.

However, these symptoms are common and can have many explanations. Persistent or unusual changes should be discussed with a healthcare professional.

For women at average risk who have no symptoms, routine ovarian cancer screening with CA-125 blood tests or transvaginal ultrasound has not been shown to reduce deaths and can lead to false-positive results and unnecessary procedures.

Women with strong family histories or known inherited risk factors should ask about genetic counseling and specialized risk management.

The important distinction: Increased incidence does not automatically mean that a routine screening test exists. For some cancers, the best current approach is risk assessment, symptom awareness and prompt evaluation rather than population-wide testing.

What can women do to take a more active role in their health?

There is no single action that eliminates cancer risk. But there are practical steps women can take to improve their chances of finding problems early and making informed decisions.

1. Establish a relationship with a primary care provider. A regular healthcare professional can help track changes, review family history, discuss screening schedules and coordinate referrals.

2. Start the breast cancer screening conversation at 40. Average-risk women should discuss the USPSTF recommendation for mammography every two years from age 40 to 74. Women with higher risk may need earlier or additional screening.

3. Know your family history. Ask relatives about breast, ovarian, pancreatic and prostate cancer diagnoses. The age at which family members were diagnosed can be important.

4. Ask about breast density. Understand what your mammogram report says and whether additional imaging is appropriate based on your overall risk.

5. Discuss menopause treatment openly. Ask about the benefits and risks of hormone therapy, alternatives for symptom relief and how your personal medical history affects those decisions.

6. Pay attention to metabolic health. Maintaining a healthy weight, staying physically active, limiting alcohol and avoiding tobacco can help reduce the risk of several cancers.

7. Do not ignore symptoms. New breast changes, unexplained bleeding after menopause, persistent digestive symptoms or unexplained weight loss should be evaluated.

8. Ask about financial assistance before delaying care. Hospitals, state health departments, nonprofit organizations and federal screening programs may offer help.

9. Follow through after an abnormal result. A screening test is only one step. Diagnostic imaging, biopsies and specialist appointments matter just as much.

The mental health side of a cancer diagnosis

There is another part of the conversation that often receives less attention: the emotional impact of cancer risk, screening and diagnosis.

For women already navigating menopause, the possibility of cancer can add another layer of anxiety. They may be dealing with sleep disruption, changes in their bodies, concerns about aging, caregiving responsibilities and uncertainty about their health.

For a woman who receives an abnormal mammogram, the waiting period between the initial result and a definitive answer can be extremely stressful.

For a woman diagnosed with cancer, the emotional impact can extend well beyond the initial diagnosis. Treatment can affect body image, relationships, intimacy, fertility, finances, employment and family responsibilities.

Black women and other underserved communities may also face the additional burden of navigating a healthcare system where they do not always feel heard, understood or supported.

Mental health support should be considered part of comprehensive cancer care, not an optional extra. Access to counselors, support groups, patient navigators and survivorship services can help women and their families manage the experience.

Caregivers also need support. A diagnosis affects partners, children, parents and other family members who may suddenly become responsible for transportation, appointments, meals and daily care.

The next step: Moving from awareness to action

Breast cancer awareness campaigns have helped bring the disease into the public conversation. But awareness alone is not enough.

Women need access to affordable screening. They need healthcare professionals who understand their individual risk. They need clear information about menopause and hormone therapy. They need diagnostic follow-up that does not take months. And when cancer is found, they need access to quality treatment regardless of their income or background.

The increase in certain cancers among younger adults makes this conversation even more urgent. Researchers still have much to learn about why these patterns are changing, but women should not have to wait for every scientific answer before receiving better education and access to care.

The healthcare system must also look beyond the number of mammograms performed. It must ask whether women receive timely results, whether abnormal findings are investigated, whether biopsies are accessible and whether patients can afford the treatment that follows.

For women entering their 40s, moving through perimenopause or adjusting to life after menopause, this is an important time to take stock of their health.

The goal is not to make women afraid of cancer. It is to make sure they are informed, heard and able to act before a problem becomes more difficult to treat.